NovaBay Pharmaceuticals, Inc. Weighted Average Shares Growth

Weighted Average Shares Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Weighted Average Shares Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Weighted Average Shares Growth for the quarter ending September 30, 2022 was 24.96% (a -125.88% decrease compared to previous quarter)
  • Year-over-year quarterly Weighted Average Shares Growth decreased by -125.92%
  • Annual Weighted Average Shares Growth for 2021 was 24.46% (a -60.61% decrease from previous year)
  • Annual Weighted Average Shares Growth for 2020 was 62.09% (a 122.7% increase from previous year)
  • Annual Weighted Average Shares Growth for 2019 was 27.88% (a 167.05% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Weighted Average Shares Growth of NovaBay Pharmaceuticals, Inc.

Most recent Weighted Average Shares Growthof NBY including historical data for past 10 years.

Interactive Chart of Weighted Average Shares Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Weighted Average Shares Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 24.96% -96.46% -96.57%
2021 -96.31% -96.79% 40.08% 49.34% 24.46%
2020 62.08% 73.35% 63.24% 63.68% 62.09%
2019 27.89% 35.15% 8.92% 4.19% 27.88%
2018 10.42% 11.52% 11.63% 7.34% 10.44%
2017 62.88% 40.42% 106.67% 274.06% -95.35%
2016 237.93% 269.06% 179.19% 87.86% 237.93%
2015 40.25% 45.46% 30.64% 19.93% 40.25%
2014 29.99% 35.64% 36.23% 23.35% 29.99%
2013 29.64% 29.83% 29.98% 28.64% 29.64%
2012 14.26% 3.43% 22.1% 21.96% 14.26%
2011 -12.48% -12.48%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology